ID
11787
Beschrijving
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia; ODM derived from: http://clinicaltrials.gov/show/NCT02034227
Link
http://clinicaltrials.gov/show/NCT02034227
Trefwoorden
Versies (3)
- 03-08-15 03-08-15 - Julian Varghese
- 03-08-15 03-08-15 - Julian Varghese
- 20-09-21 20-09-21 -
Geüploaded op
3 augustus 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Acute Myeloid Leukemia NCT02034227
Eligibility Acute Myeloid Leukemia NCT02034227
- StudyEvent: Eligibility Acute Myeloid Leukemia NCT02034227
Beschrijving
Exclusion Criteria
Beschrijving
are eligible for any standard therapy known to be life prolonging or life saving
Datatype
boolean
Beschrijving
have diagnosis of aml french-american-british (fab) classification (fab) m3 (acute promyelocytic leukemia (apl))
Datatype
boolean
Alias
- UMLS CUI [1]
- C0457329
Beschrijving
are receiving concurrent chemotherapy, radiotherapy, immunotherapy, biological or hormonal treatment for cancer.
Datatype
boolean
Alias
- UMLS CUI [1]
- C3665472
- UMLS CUI [2]
- C1522449
- UMLS CUI [3]
- C0021083
- UMLS CUI [4]
- C1531518
- UMLS CUI [5]
- C0279025
Beschrijving
have undergone anticancer therapy including chemotherapy (except for hydroxycarbamide at a maximum daily dose of 3000 mg), endocrine therapy, immunotherapy, or the use of other investigational agents within 4 weeks before study entry.
Datatype
boolean
Alias
- UMLS CUI [1]
- C3665472
- UMLS CUI [2]
- C0279025
- UMLS CUI [3]
- C0021083
- UMLS CUI [4]
- C0020402
Beschrijving
prior radiation therapy with volume of bone marrow treated over 25%.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C0005953
- UMLS CUI [1,3]
- C0439165
Beschrijving
use of immunosuppressive therapy, including systemic steroids within 7 days before the first dose of sg2000.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0455630
- UMLS CUI [2]
- C0149783
Beschrijving
hyperleukocytosis (blast counts >30 000/mm3).
Datatype
boolean
Alias
- UMLS CUI [1]
- C3805210
Beschrijving
history of allogeneic stem cell or solid organ transplantation.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0029216
- UMLS CUI [2]
- C2242529
Beschrijving
positive serology for human immunodeficiency virus (hiv), hepatitis b or hepatitis c or have hiv-aids, or active hepatitis b or c.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0019699
- UMLS CUI [2]
- C0744837
- UMLS CUI [3]
- C0850489
- UMLS CUI [4]
- C0001175
Beschrijving
history of other invasive malignancy within 3 years except for cervical carcinoma in situ, nonmelanomatous carcinoma of the skin or ductal carcinoma in situ of the breast that has been surgically cured.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0677898
- UMLS CUI [2]
- C0007099
- UMLS CUI [3,1]
- C0007114
- UMLS CUI [3,2]
- C1518408
Beschrijving
have any coexisting medical condition that will substantially increase the risk associated with the subject's participation in the study.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C2348568
- UMLS CUI [1,2]
- C1549479
- UMLS CUI [1,3]
- C0012634
Beschrijving
have psychiatric disorders or altered mental status precluding understanding of the informed consent process and/or completion of necessary studies.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C1549479
- UMLS CUI [1,3]
- C0004936
Beschrijving
have persistent grade 2 or greater toxicities from any cause (except alopecia or peripheral neuropathy).
Datatype
boolean
Alias
- UMLS CUI [1]
- C2826262
- UMLS CUI [2]
- C0002170
- UMLS CUI [3]
- C0031117
Beschrijving
are pregnant or breast-feeding.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0549206
- UMLS CUI [2]
- C0006147
Similar models
Eligibility Acute Myeloid Leukemia NCT02034227
- StudyEvent: Eligibility Acute Myeloid Leukemia NCT02034227
C0205269 (UMLS CUI [1,2])
C0023467 (UMLS CUI [2,1])
C0035020 (UMLS CUI [2,2])
C0001779 (UMLS CUI [3])
C0278787 (UMLS CUI [4,1])
C0332293 (UMLS CUI [4,2])
C0059985 (UMLS CUI [4,3])
C0023434 (UMLS CUI [5,1])
C0332293 (UMLS CUI [5,2])
C0002073 (UMLS CUI [5,3])
C0879626 (UMLS CUI [1,2])
C0002170 (UMLS CUI [2])
C0442874 (UMLS CUI [3])
C0332298 (UMLS CUI [1,2])
C0020402 (UMLS CUI [1,3])
C0232805 (UMLS CUI [2])
C0430064 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C1531518 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
C0279025 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C0020402 (UMLS CUI [4])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C0149783 (UMLS CUI [2])
C2242529 (UMLS CUI [2])
C0744837 (UMLS CUI [2])
C0850489 (UMLS CUI [3])
C0001175 (UMLS CUI [4])
C0007099 (UMLS CUI [2])
C0007114 (UMLS CUI [3,1])
C1518408 (UMLS CUI [3,2])
C1549479 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,3])
C1549479 (UMLS CUI [1,2])
C0004936 (UMLS CUI [1,3])
C0002170 (UMLS CUI [2])
C0031117 (UMLS CUI [3])
C0006147 (UMLS CUI [2])